Five-year outcomes of ab interno Xen 45 gel stent implantation

Journal article

Ansari, E. 2023. Five-year outcomes of ab interno Xen 45 gel stent implantation. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. https://doi.org/10.1007/s00417-023-06294-9
AuthorsAnsari, E.
AbstractTo assess the safety and 5-year efficacy of ab interno XEN 45 gel stent implantation with phacoemulsification in primary open-angle glaucoma (POAG). Single-centre, single-surgeon, retrospective case note review of consecutive OAG patients who underwent ab-interno gel stent placement combined with phacoemulsification. Surgeries were performed between 2/01/2014 and 2/01/2016. mean reduction in intraocular pressure (IOP) and change in number of ocular hypotensive medications from baseline (follow-up range 1-7 years; mean 54 months). change in visual field mean deviation (VFMD) from baseline. Safety data included intraoperative and post-operative complications and adverse events. Failure was defined by IOP reduction < 20% despite maximum medical therapy, the need for further laser or surgical intervention. At 5 years, 75% of eyes were free from failure (95% CI 64 to 83%). Ninety-one eyes were analysed. Mean (SD) IOP and medications decreased from 20.2 (6.4) mmHg and 2.9 (1.0) at baseline to 15.4 (3.6) mmHg (p < 0.001) and 1.5 (1.4) medications at 5 (p < 0.001) years. Baseline mean VFMD (SD) was - 10.3dB (8.5) reducing to - 10.9(8.2) (p < 0.01) at 5 years. Two (2%) eyes had intraoperative complications, 4 (4.3%) experienced post-operative AEs, and 13 (14%) required secondary surgical intervention (SSI). The gel stent combined with phacoemulsification was effective in reducing IOP and medications over 5 years, with an acceptable safety profile. Visual field change was clinically acceptable through the study period. [Abstract copyright: © 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.]
KeywordsGlaucoma; MIGS; Visual fields; Medication; XEN gel stent; Intraocular pressure (IOP)
Year2023
JournalGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
PublisherSpringer
ISSN1435-702X
Digital Object Identifier (DOI)https://doi.org/10.1007/s00417-023-06294-9
Official URLhttps://link.springer.com/article/10.1007/s00417-023-06294-9
Publication dates
Online13 Nov 2023
Publication process dates
Accepted23 Oct 2023
Deposited27 Nov 2023
Output statusPublished
Permalink -

https://repository.canterbury.ac.uk/item/96726/five-year-outcomes-of-ab-interno-xen-45-gel-stent-implantation

  • 42
    total views
  • 0
    total downloads
  • 2
    views this month
  • 0
    downloads this month

Export as

Related outputs

Graves' ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions - a systematic review.
Bello, Oyinola Maria, Druce, Maralyn and Ansari, Ejaz 2024. Graves' ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions - a systematic review. BMJ open ophthalmology. 9 (1), p. e001515. https://doi.org/10.1136/bmjophth-2023-001515
The BVI ISOPURE ® 123 intraocular lens: a new hydrophobic preloaded extended monofocal IOL with intermediate vision correction
Ansari, Ejaz 2024. The BVI ISOPURE ® 123 intraocular lens: a new hydrophobic preloaded extended monofocal IOL with intermediate vision correction. Frontiers in Ophthalmology. 3, p. 1330335. https://doi.org/10.3389/fopht.2023.1330335
5-year outcomes of single iStent (G1) trabecular microbypass implantation with phacoemulsification in moderately advanced primary open angle glaucoma
Ansari, E. 2021. 5-year outcomes of single iStent (G1) trabecular microbypass implantation with phacoemulsification in moderately advanced primary open angle glaucoma. PLoS ONE. 16 (9), p. e0257015. https://doi.org/10.1371/journal.pone.0257015